Author

myneuronews

Traumatic brain injury
FastSurfer parcellation accuracy after lesion filling in moderate-to-severe traumatic brain injury

by myneuronews December 26, 2025

by myneuronews December 26, 2025

Study Overview The research focuses on evaluating the accuracy of FastSurfer parcellation, particularly following the …

Read more

0 Facebook Twitter Pinterest Email
Dementia
Biomarkers

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Biomarker Definition and Types Biomarkers are biological indicators that are used to measure and evaluate …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Clinical Manifestations

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Overview of Clinical Manifestations Clinical manifestations refer to the observable or measurable signs and symptoms …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Biomarkers

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Biomarker Definition and Significance Biomarkers are measurable indicators that reflect biological processes, pathogenic processes, or …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
External validation of the modified Brain Injury Guidelines: an observational study

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Study Overview This observational study focuses on the external validation of the modified Brain Injury …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Biomarkers

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Definition and Types Biomarkers are biological indicators that provide insights into the physiological or pathological …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Is tranexamic acid effective for all traumatic brain injury patients? a severity based systematic review and meta-analysis

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Effectiveness of Tranexamic Acid Tranexamic acid, an antifibrinolytic medication, has garnered attention for its potential …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Office-based Neurophysiological Assessments for Diagnosis and Prognosis of Concussion

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Clinical Relevance The assessment of concussion plays a significant role in both the immediate and …

Read more

0 Facebook Twitter Pinterest Email
Headaches
Factors contributing to inaccurate migraine diagnosis: a prospective study at a tertiary hospital in Southern Thailand

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Factors Leading to Misdiagnosis Misdiagnosis of migraines can occur due to a plethora of factors …

Read more

0 Facebook Twitter Pinterest Email
Traumatic brain injury
Clinical Manifestations

by myneuronews December 25, 2025

by myneuronews December 25, 2025

Common Symptoms The manifestation of various diseases often presents a spectrum of symptoms that can …

Read more

0 Facebook Twitter Pinterest Email

Prevalence of post-traumatic hypopituitarism in active-duty service members receiving comprehensive care for traumatic brain injury (TBI) and psychological health: A military mild TBI cohort study
Objective: The prevalence of neuroendocrine dysfunction (NED) following mild traumatic brain injury (mTBI) remains obscure, with widely varying prevalence estimates. This study aimed to determine prevalence of NED among central hypogonadism, central hypothyroidism, and growth hormone deficiency (GHD) in active-duty military service members (SMs) receiving comprehensive TBI and psychological health care and characterize TBI burden, […]
A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults
CONCLUSION: Treatment with INRSA was associated with improvement in mild TBI outcome, which represents a new potential option for the pharmacological treatment of non-fatal head injury. Further studies might be of research interest and clinical demand.
CT Brain Utilization After Low-Risk Head Injury in Adults: A Retrospective Cohort Study and Literature Review
Introduction Falls in adults aged ≥65 years contribute substantially to emergency department presentations and mild traumatic brain injury, with variable risk of intracranial hemorrhage. Existing CT decision tools often exclude older adults, resulting in potentially unnecessary imaging. This study aimed to identify predictors of intracranial pathology in all adults and compare older versus younger patients […]
Loss of Fatty Acid Oxidation by Neural Stem and Progenitor Cells Increases Proliferation but Does Not Improve Long-Term Neurogenesis After Mild Traumatic Brain Injury
Neurogenesis in the dentate gyrus of the hippocampus is a conserved and highly regulated process throughout the lifespan. Hippocampal neural stem and progenitor cells (NSPCs) can either transition into an activated proliferative state or remain quiescent. Accumulating data suggests that mitochondrial fatty acid β-oxidation is important in maintaining NSPCs quiescence under normal physiological conditions; however, […]
Corrigendum to 'Anti-Inflammatory, Antioxidant and Neuroprotective Effects of Niacin on Mild Traumatic Brain Injury in Rats.'
Corrigendum to 'Anti-Inflammatory, Antioxidant and Neuroprotective Effects of Niacin on Mild Traumatic Brain Injury in Rats.' . . . . . . . . . . . . . . . . . . . . .. . . . .. . . . . .. . . . . . . . . .. […]